Abstract:Background CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). Methods To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. Findings In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Interpretation Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population. CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population.

A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population

Genetic Polymorphisms of Xrcc1 Gene and Susceptibility to Hepatocellular Carcinoma in Chinese Population

The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.

The NAD(P)H: Quinine Oxidoreductase 1 (NQO1) Gene 609 C>T Polymorphism is Associated with Gastric Cancer Risk: Evidence from a Case-Control Study and a Meta-Analysis.

NAD(P)H: Quinone Oxidoreductase 1 (NQO1) C609T Polymorphism and Lung Cancer Risk: a Meta-Analysis.

A Functional Nqo1 609c > T Polymorphism and Risk of Gastrointestinal Cancers: A Meta-Analysis

Impact of NOTCH1 Polymorphisms on Liver Cancer in a Chinese Han Population

An Association Between a NQO1 Genetic Polymorphism and Risk of Lung Cancer

Lack Of Association Between Nadph Quinone Oxidoreductase 1 (Nqo1) Gene C609t Polymorphism And Lung Cancer: A Case-Control Study And A Meta-Analysis

Genetic Association Of Nqo1 609c>T Polymorphism With Risk Of Gastrointestinal Cancer: Evidence From Case-Control Studies

Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis

Association between NQO1 C609T polymorphism and prostate cancer risk

The NAD(P)H:quinone Oxidoreductase 1 Gene Polymorphism and Lung Cancer

Cyclooxygenase-2 Gene Polymorphisms and Susceptibility to Hepatocellular Carcinoma

A Systematic Analysis Between NQO1 Gene Polymorphism and Susceptibility of Lung Cancer

An association between NQO1 genetic polymorphism and risk of bladder cancer.

[Relationship Between Quinone Oxidoreductase1 Gene Ns-Csnp and Genetic Susceptibility of Esophageal Cancer].

P0162 CYP1B1 Polymorphisms and Hepatocellular Cancer Risk in a Chinese Population

Functional Polymorphisms, Altered Gene Expression and Genetic Association Link NRH:quinone Oxidoreductase 2 to Breast Cancer with Wild-Type P53.

Common Genetic Variations Of The Cytochrome P450 1a1 Gene And Risk Of Hepatocellular Carcinoma In A Chinese Population

Abstract 1439: Meta-analysis of the NQO1 gene C609T polymorphism: Increased risk of colorectal cancer